Eli Lilly is leading the market for GLP-1 medications (for weight loss and diabetes). In a decade, Eli Lilly could be in the ...

People on weight loss medications are being warned not to follow the latest microdosing trend which has been gaining ...

People may be risking serious infections, slowed progress and lipohypertrophy by taking smaller doses of their weight loss medication ...

When it comes to treating depression, one size definitely does not fit all, and they're not the answer for everyone.

For more than two years it had the entirety of the market for weight-loss drugs to itself. By 2023 sales of Wegovy had ...

Eli Lilly could extend its lead in its core therapeutic area with the launch of two new products next year. The company also ...

Obesity is a big driver of healthcare spending in South Africa, yet most medical schemes still limit cover for effective ...

Tom Standage, editor of The World Ahead, and Alex Hern, our AI writer, consider the technologies to watch in the coming year.

From shifting grocery habits to new product opportunities, Circana’s insights reveal how brands and retailers can adapt to ...